This inventor holds 6 USPTO granted patents and 15 published patent applications and 2 EPO patents. Top assignee: Nuclera Ltd. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: The Innovations of Michael Chun Hao Chen in Nucleic Acid Synthesis
Introduction
Michael Chun Hao Chen is a notable inventor based in Cambridge, GB, recognized for his significant contributions to the field of nucleic acid synthesis. With a total of four patents to his name, Chen's work focuses on engineered enzymes that enhance various biochemical processes. His innovative approaches have garnered attention in both academic and commercial sectors.
Latest Patents
One of Chen's most recent patents centers on modified terminal deoxynucleotidyl transferase (TdT) enzymes. This invention pertains to engineered TdT enzymes or the homologous amino acid sequences of various polymerases, specifically Polμ, Polβ, Polλ, and Polθ, across different species. The patent details methods for synthesizing nucleic acids utilizing these advanced enzymes and the innovative use of kits that incorporate these enzymes for nucleic acid synthesis. Additionally, the invention explores the application of new terminal deoxynucleotidyl transferases and 3'-blocked nucleoside triphosphates in template-independent nucleic acid synthesis, showcasing a leap in biotechnology methods.
Career Highlights
Michael Chun Hao Chen makes significant strides in the biotechnology sector as a key player at Nuclera Ltd. His role involves spearheading innovative projects that develop tools and methods for nucleic acid synthesis, reflecting his commitment to advancing genetic research and applications. Through his inventive work, Chen has positioned himself as a critical contributor to the evolving landscape of genetic engineering.
Collaborations
Chen collaborates with notable colleagues such as Gordon R McInroy and Sumit Kalsi, contributing to a dynamic environment of creativity and innovation. Their joint efforts enhance research outcomes and push the boundaries of what's possible in nucleic acid technology.
Conclusion
Michael Chun Hao Chen's work exemplifies the spirit of innovation within the field of biotechnology. With his latest patents focusing on advanced enzymes for nucleic acid synthesis, he continues to influence research and application in the life sciences. As Chen and his team at Nuclera Ltd. propel forward, the potential impact of their inventions on genetic technology is bound to be profound.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile